StonvexLoading…
StonvexStonvexStonvexCore line items from ECL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.07B | $16.08B | $11.89B | $7.72B |
Operating Income | $622.00M | $2.74B | $2.03B | $1.27B |
Net Income | $432.60M | $2.08B | $1.51B | $926.70M |
EPS (Diluted) | $1.52 | $7.28 | $5.30 | $3.25 |
Total Assets | $25.04B | $24.70B | $23.90B | $23.74B |
Total Liabilities | $15.01B | $14.89B | $14.14B | $14.39B |
Cash & Equivalents | $519.80M | $646.20M | $1.96B | $1.92B |
Free Cash Flow OCF − CapEx | $97.40M | $1.90B | $1.15B | $616.60M |
Shares Outstanding | 281.40M | 282.00M | 283.20M | 283.60M |